Molecular subtypes for breast cancer consider the expression of Ki-67, estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2) [4, 5]. This evidence concerns the gene PGR and breast carcinoma.